GlycoMimetics Inc (GLYC)
0.3168
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
0.3133
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Stock Buybacks (Quarterly): 0.00 for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | -28.71M |
December 31, 2022 | -4.157M |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | -1.140M |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | -9.560M |
December 31, 2020 | -3.705M |
September 30, 2020 | -4.545M |
June 30, 2020 | -9.574M |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | |
December 31, 2018 | 0.00 |
Date | Value |
---|---|
September 30, 2018 | 0.00 |
June 30, 2018 | 0.2089M |
March 31, 2018 | -128.63M |
December 31, 2017 | -19.30M |
September 30, 2017 | 0.1363M |
June 30, 2017 | -90.74M |
March 31, 2017 | -3.668M |
December 31, 2016 | -1.148M |
September 30, 2016 | 0.1358M |
June 30, 2016 | -21.35M |
March 31, 2016 | -1.239M |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.0082M |
March 31, 2014 | -57.26M |
December 31, 2013 | |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-28.71M
Minimum
Mar 2023
--
Maximum
Dec 2019
-3.069M
Average
--
Median
Dec 2019
Stock Buybacks (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | -- |
Arbutus Biopharma Corp | 0.00 |
Revance Therapeutics Inc | 0.00 |
FibroGen Inc | 0.00 |
Cidara Therapeutics Inc | 0.107M |